Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

Bibliographic Details
Main Authors:	Marigdalia K. Ramirez-Fort, Casey K. Gilman, Jacob S. Alexander, Barbara Meier-Schiesser, Arjan Gower, Mojtaba Olyaie, Neel Vaidya, Kiarash Vahidi, Yuxin Li, Christopher S. Lange, Migdalia Fort, Corinne Deurdulian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Medicine
Subjects:	folate hydrolase-1 prostate-specific membrane antigen theragnostic target gender-inclusive language disease-inclusive language
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1304718/full

Similar Items

Human papillomavirus induced periungual pigmented Bowen’s disease
by: Marigdalia K. Ramirez-Fort
Published: (2012-01-01)

Dermoscopy: What is your diagnosis?
by: Barry Ladizinski, et al.
Published: (2013-07-01)

Hyperkeratotic necrobiosis lipoidica
by: Farhan Khan, et al.
Published: (2013-01-01)

Bacteriophages as Solid Tumor Theragnostic Agents
by: Srivani Veeranarayanan, et al.
Published: (2021-12-01)

Lichenoid keratosis: non-invasive imaging in the setting of diagnostic uncertainty
by: Marigdalia Ramirez-Fort, et al.
Published: (2013-04-01)

SkIndia Quiz 25: A solitary nodule on the right buttock
by: Reza Yaghoobi, et al.
Published: (2016-01-01)

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA
by: Hans-S. Jans, et al.
Published: (2022-08-01)

Polymeric Theragnostic Nanoplatforms for Bone Tissue Engineering
by: Kaushita Banerjee, et al.
Published: (2023-07-01)

Molecular Imaging and Theragnostics of Thyroid Cancers
by: Luca Giovanella, et al.
Published: (2022-03-01)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
by: Andrea Cimini, et al.
Published: (2020-05-01)

Digit-length ratios (2D:4D) as a phenotypic indicator of in utero androgen exposure is not prognostic for androgenic alopecia: a descriptive-analytic study of 1200 Iranian men
by: Amir Feily, et al.
Published: (2016-06-01)

Microfluidic Fabrication of Gadolinium-Doped Hydroxyapatite for Theragnostic Applications
by: Manuel Somoza, et al.
Published: (2023-01-01)

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
by: Alessio Rizzo, et al.
Published: (2022-08-01)

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications
by: Min Seok Kang, et al.
Published: (2023-05-01)

From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model
by: Giuseppe Danilo Di Stasio, et al.
Published: (2021-07-01)

Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
by: Sónia A. Pinho, et al.
Published: (2023-05-01)

Nuclear Medicine and Cancer Theragnostics: Basic Concepts
by: Vasiliki Zoi, et al.
Published: (2023-09-01)

Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates
by: Wolfgang Lilleby, et al.
Published: (2011-06-01)

Synthesis and Characterization of Magnetic Composite Theragnostics by Nano Spray Drying
by: Caio José Perecin, et al.
Published: (2022-02-01)

Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome Activation
by: Barbara Meier-Schiesser, et al.
Published: (2021-11-01)

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
by: Virginia Liberini, et al.
Published: (2022-06-01)

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma
by: M. K. Ramirez‐Fort, et al.
Published: (2021-03-01)

Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent
by: Quetzali Pitalua-Cortes, et al.
Published: (2021-12-01)

PSMA theragnostics for metastatic castration resistant prostate cancer
by: Hong Song, et al.
Published: (2022-08-01)

Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs)
by: Michele Balma, et al.
Published: (2023-07-01)

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach
by: Iacopo Petrini, et al.
Published: (2022-05-01)

Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
by: Rama Jayaraj, et al.
Published: (2020-05-01)

LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis
by: Ping Lin, et al.
Published: (2022-05-01)

Theragnostic Radionuclide Pairs for Prostate Cancer Management: <sup>64</sup>Cu/<sup>67</sup>Cu, Can Be a Budding Hot Duo
by: Anupriya Chhabra, et al.
Published: (2022-11-01)

Entrusting the Past to the Present: Confessional Writing in Three Novels by William Golding
by: Camille Fort
Published: (2010-06-01)

Goat milk extracellular vesicles: Separation comparison of natural carriers for theragnostic application
by: Jessie Santoro, et al.
Published: (2024-03-01)

Nanocarrier systems loaded with IR780, iron oxide nanoparticles and chlorambucil for cancer theragnostics
by: Phuong-Thao Dang-Luong, et al.
Published: (2024-02-01)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
by: Mai Lin, et al.
Published: (2022-10-01)

Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
by: Gabriela Capriotti, et al.
Published: (2022-12-01)

Inclusive Education and ELT Policies in Colombia: Views From Some PROFILE Journal Authors
by: Lina María Robayo Acuña, et al.
Published: (2017-01-01)

The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris
by: Amir Feily, MD, et al.
Published: (2020-03-01)

Assessing Children with Language Impairments: A Study on Kannada, a South Indian Language
by: Srimani Chakravarthi
Published: (2012-12-01)

Theragnostic Glycol Chitosan-Conjugated Gold Nanoparticles for Photoacoustic Imaging of Regional Lymph Nodes and Delivering Tumor Antigen to Lymph Nodes
by: In-Cheol Sun, et al.
Published: (2021-06-01)

Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs)
by: Lorena-Andreea Bocancia-Mateescu, et al.
Published: (2023-06-01)

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice
by: Aikaterini Kaloudi, et al.
Published: (2017-11-01)